We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+4.84%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$191B
AUM Growth
+$34.6B
(+22%)
Cap. Flow
+$29.9B
Cap. Flow
% of AUM
15.69%
Top 10 Holdings %
Top 10 Hldgs %
11.5%
Holding
3,667
New
211
Increased
2,098
Reduced
1,163
Closed
105
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Atlassian
TEAM
|
+$905M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$786M |
| 3 |
NVIDIA
NVDA
|
+$736M |
| 4 |
Centene
CNC
|
+$642M |
| 5 |
Apple
AAPL
|
+$451M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Molina Healthcare
MOH
|
+$415M |
| 2 |
Intel
INTC
|
+$329M |
| 3 |
General Motors
GM
|
+$237M |
| 4 |
DoorDash
DASH
|
+$225M |
| 5 |
Intuit
INTU
|
+$187M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.3% |
| 2 | Financials | 15.19% |
| 3 | Healthcare | 12.58% |
| 4 | Consumer Discretionary | 12.42% |
| 5 | Industrials | 12.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3476
Enovix
ENVX
$1.05B
| $79.4K | ﹤0.01% |
10,860
-2,158
| -17% | -$20.9K |
|
3477
Stereotaxis
STXS
$145M
| $79.3K | ﹤0.01% |
34,490
-1,972
| -5% | -$5.25K |
|
3478
Ranpak Holdings
PACK
$461M
| $78.7K | ﹤0.01% |
14,547
+910
| +7% | +$4.78K |
|
3479
Protara Therapeutics
TARA
$220M
| $78.3K | ﹤0.01% |
+14,681
| New | +$81.6K |
|
3480
Altimmune
ALT
$583M
| $76.3K | ﹤0.01% |
+21,147
| New | +$92.2K |
|
|
TSSI
3481
TSS Inc
TSSI
$320M
| $76K | ﹤0.01% |
10,752
-12,177
| -53% | -$157K |
|
3482
Aura Biosciences
AURA
$832M
| $75.5K | ﹤0.01% |
13,862
-3,295
| -19% | -$19.6K |
|
3483
Butterfly Network
BFLY
$2.5B
| $74.6K | ﹤0.01% |
19,631
-7,945
| -29% | -$21.6K |
|
|
ASM
3484
Avino Silver & Gold Mines
ASM
$1.29B
| $74.5K | ﹤0.01% |
12,000
| – | – |
|
3485
Foghorn Therapeutics
FHTX
$391M
| $73.2K | ﹤0.01% |
13,550
-4,228
| -24% | -$19.2K |
|
|
BHR
3486
Braemar Hotels & Resorts
BHR
$138M
| $72.7K | ﹤0.01% |
25,342
+7,973
| +46% | +$21.5K |
|
|
ONL
3487
Orion Office REIT
ONL
$158M
| $72.4K | ﹤0.01% |
32,038
-15,660
| -33% | -$36.9K |
|
3488
Ispire Technology
ISPR
$99.9M
| $70K | ﹤0.01% |
25,009
-7,354
| -23% | -$17.1K |
|
3489
KULR Technology Group
KULR
$130M
| $69.9K | ﹤0.01% |
23,614
+9,098
| +63% | +$33.4K |
|
3490
Algonquin Power & Utilities
AQN
$4.47B
| $69.2K | ﹤0.01% |
11,252
-19,757
| -64% | -$117K |
|
3491
Palladyne AI
PDYN
$312M
| $68.6K | ﹤0.01% |
16,096
-8,218
| -34% | -$55.3K |
|
|
NXXT
3492
NextNRG Inc
NXXT
$47M
| $67.7K | ﹤0.01% |
46,719
-11,137
| -19% | -$19.2K |
|
3493
Orchestra BioMed
OBIO
$263M
| $67.6K | ﹤0.01% |
16,290
-822
| -5% | -$3.32K |
|
3494
Bit Digital
BTBT
$471M
| $67.1K | ﹤0.01% |
35,501
-1,013
| -3% | -$2.93K |
|
3495
Torrid Holdings
CURV
$239M
| $66.4K | ﹤0.01% |
67,884
+3,796
| +6% | +$4.85K |
|
|
FSP
3496
Franklin Street Properties
FSP
$45.8M
| $65.8K | ﹤0.01% |
69,562
-26,000
| -27% | -$30.2K |
|
3497
PodcastOne
PODC
$100M
| $65.6K | ﹤0.01% |
26,559
| – | – |
|
3498
PLAYSTUDIOS Inc
MYPS
$81.1M
| $64.9K | ﹤0.01% |
99,615
-7,806
| -7% | -$6.08K |
|
3499
Paysign
PAYS
$713M
| $64.5K | ﹤0.01% |
12,515
-90
| -0.7% | -$485 |
|
3500
Zentalis Pharmaceuticals
ZNTL
$295M
| $62.1K | ﹤0.01% |
45,995
-60,970
| -57% | -$88.7K |
|
Similar funds
VGA
AQR Capital Management's Q4 2025 Portfolio in Review
As of Q4 2025, AQR Capital Management held 3,667 positions worth $191B, up 22% from $156B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
AQR Capital Management deployed $29.9B of net new capital in Q4 2025, opening 211 new positions and adding to 2,098 existing holdings. Its largest new stake was Celestica: 1,066,543 shares worth $315M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Molina Healthcare, an estimated $415M trimmed.
- AQR Capital Management's largest Q4 2025 buy was Celestica: 1,066,543 shares worth $315M.
- AQR Capital Management added most to Atlassian in Q4 2025, an estimated $905M increase.
- AQR Capital Management's biggest Q4 2025 reduction was Molina Healthcare, cutting an estimated $415M.
- AQR Capital Management fully exited Light & Wonder in Q4 2025, selling an estimated $70.7M.
- AQR Capital Management's ten largest holdings make up 12% of its $191B portfolio in Q4 2025.
- AQR Capital Management opened 211 new positions and closed 105 in Q4 2025.
- AQR Capital Management's portfolio value rose 22% quarter-over-quarter to $191B.
Based on AQR Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.